161 related articles for article (PubMed ID: 9020485)
21. Establishment of long-term in vitro cultures of human ovarian cystadenomas and LMP tumors and examination of their spectrum of expression of matrix-degrading proteinases.
Luo MP; Gomperts B; Imren S; DeClerck YA; Ito M; Velicescu M; Felix JC; Dubeau L
Gynecol Oncol; 1997 Dec; 67(3):277-84. PubMed ID: 9441775
[TBL] [Abstract][Full Text] [Related]
22. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential.
Qu G; Dubeau L; Narayan A; Yu MC; Ehrlich M
Mutat Res; 1999 Jan; 423(1-2):91-101. PubMed ID: 10029684
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
[TBL] [Abstract][Full Text] [Related]
24. Histologically benign or low-grade malignant tumors adjacent to high-grade ovarian carcinomas contain molecular characteristics of high-grade carcinomas.
Zheng J; Wan M; Zweizig S; Velicescu M; Yu MC; Dubeau L
Cancer Res; 1993 Sep; 53(18):4138-42. PubMed ID: 8364906
[TBL] [Abstract][Full Text] [Related]
25. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential.
Gu J; Roth LM; Younger C; Michael H; Abdul-Karim FW; Zhang S; Ulbright TM; Eble JN; Cheng L
J Natl Cancer Inst; 2001 Aug; 93(15):1147-52. PubMed ID: 11481386
[TBL] [Abstract][Full Text] [Related]
26. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
27. Allelic imbalance is not restricted to numerically abnormal chromosomes in epithelial ovarian tumours.
Evans MF; Herrington CS
J Pathol; 2001 Nov; 195(4):443-50. PubMed ID: 11745676
[TBL] [Abstract][Full Text] [Related]
28. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
[TBL] [Abstract][Full Text] [Related]
29. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.
Weichert W; Denkert C; Schmidt M; Gekeler V; Wolf G; Köbel M; Dietel M; Hauptmann S
Br J Cancer; 2004 Feb; 90(4):815-21. PubMed ID: 14970859
[TBL] [Abstract][Full Text] [Related]
30. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression.
Saegusa M; Machida D; Hashimura M; Okayasu I
J Pathol; 1999 Nov; 189(3):326-37. PubMed ID: 10547593
[TBL] [Abstract][Full Text] [Related]
31. p63 expression in epithelial ovarian tumors.
Poli Neto OB; Candido Dos Reis FJ; Zambelli Ramalho LN; Nogueira AA; de Andrade JM
Int J Gynecol Cancer; 2006; 16(1):152-5. PubMed ID: 16445626
[TBL] [Abstract][Full Text] [Related]
32. X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas.
Park TW; Felix JC; Wright TC
Cancer Res; 1995 Nov; 55(21):4793-6. PubMed ID: 7585507
[TBL] [Abstract][Full Text] [Related]
33. [Serous borderline ovarian tumors].
Zipprich K; Albrecht G; Canzler E
Zentralbl Gynakol; 1985; 107(3):159-68. PubMed ID: 3984570
[TBL] [Abstract][Full Text] [Related]
34. Expression of cadherins and CD44 isoforms in ovarian endometrial cysts.
Daraï E; Leblanc M; Walker-Combrouze F; Bringuier AF; Madelenat P; Scoazec JY
Hum Reprod; 1998 May; 13(5):1346-52. PubMed ID: 9647570
[TBL] [Abstract][Full Text] [Related]
35. No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms.
Shih YC; Kerr J; Hurst TG; Khoo SK; Ward BG; Chenevix-Trench G
Gynecol Oncol; 1998 Jun; 69(3):210-3. PubMed ID: 9648589
[TBL] [Abstract][Full Text] [Related]
36. Impaired FHIT expression characterizes serous ovarian carcinoma.
Ozaki K; Enomoto T; Yoshino K; Fujita M; Buzard GS; Kawano K; Yamasaki M; Murata Y
Br J Cancer; 2001 Jul; 85(2):247-54. PubMed ID: 11461085
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.
Wu Q; Lothe RA; Ahlquist T; Silins I; Tropé CG; Micci F; Nesland JM; Suo Z; Lind GE
Mol Cancer; 2007 Jul; 6():45. PubMed ID: 17623056
[TBL] [Abstract][Full Text] [Related]
38. Ovarian epithelial tumors of low malignant potential: are they precursors of ovarian carcinoma?
Fukumoto M; Nakayama K
Pathol Int; 2006 May; 56(5):233-9. PubMed ID: 16669871
[TBL] [Abstract][Full Text] [Related]
39. Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A (CDKN2A) in ovarian cancer.
Abou-Zeid AA; Azzam AZ; Kamel NA
Scand J Clin Lab Invest; 2011 Nov; 71(7):542-7. PubMed ID: 21728901
[TBL] [Abstract][Full Text] [Related]
40. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]